7th Annual Brain Mets congress, October 6-7, 2017, Marseille, France


We are pleased to welcome you to Marseille for the Seventh Annual Brain Metastases Research and Emerging Therapy Conference.


This year again the meeting will be held under the auspices of EORTC (European Organisation for Research and Treatment of Cancer), EANO (European Association of Neuro-Oncology) and EANS (The European Association of Neurosurgical Societies). Also ANOCEF (French Neuro-oncology group) and SFNC (French Society of Neurosurgery) are partners of this event.
We are pleased to welcome you to Marseille for the Seventh Annual Brain Metastases Research and Emerging Therapy Conference.

This initiative brings the multidisciplinary approach needed to develop Brain Metastases projects across several tumor types and disciplines such as breast cancer, lung cancer, melanoma, imaging, radiation oncology, pathology and molecular. It is expected that this cross-sectional meeting will stimulate innovative and insightful research in a collaborative environment and improve the standard of care and methodology of clinical research. For this 7th edition, a special session will be dedicated to Immuno-oncology in CNS Metastases. Actually, cancer immunotherapy clinical trials are critical to bringing new and potentially lifesaving treatments to more patients with more types of cancer, and may represent the greatest hope especially for patients currently facing Brain Metastases. Highlighted topics will also cover adverse radiation effect in the era of targeted therapies, new pharmalogical approaches and combined treatments in BM.

One of the objectives of this edition will be to describe the clinical problem, identify the critical points of therapeutic failure and summarize the current state of knowledge of the genetics and biology of Brain Metastases. The overarching goal of the meeting is to generate a set of research priorities that would stimulate integrated scientific and clinical investigation directed at understanding basic processes of brain metastasis and translating such insights to clinical care.

The organizing committee hopes that this meeting will provide an exceptional opportunity for you to share your collective expertise ranging from basic science to new treatments in order to facilitate ongoing studies and lay the foundation for future collaborative projects.


Diagnostic approaches
Immuno-oncology in CNS Metastases
Combined treatments for CNS Metastases
Comprehensive care of patients with Brain Metastases
Interactive case reports (progression/criteria of evaluation)
Activities of EORTC BTG CNS Metastases Committee
Highlights 2016-2017
Selected oral abstract

Call for abstracts, deadline August 29th, 2017

View website & program